An estimated one in eight Americans has now tried a GLP-1 medication like Ozempic or WeGovy: to lose weight, manage diabetes or experiment with anecdotal, off-label benefits. Yet GLP-1s can be hard to talk about — whether you want to ask someone if they take one, respond if you do, or discuss weight without dredging up unhealthy diet discourse. We’ll hear how you’re navigating these conversations in the age of GLP-1s. Tell us: How are GLP-1s showing up in your world?

Guests:

Diana Thiara, medical director, UCSF Weight Loss Management Program

Whitney Casares, pediatrician; author, “Raising Body-Confident Kids” and “My One-Of A-Kind Body: The Ultimate Guide to Caring for Me”

Angela Corral, senior editor, KQED’s The California Report; she has been been taking a GLP-1 for almost 2 years

Learn more about your ad choices. Visit megaphone.fm/adchoices